Chronic treatment of mice with aldosterone following a myocardial infarction led to increased CaMKII oxidation and subsequent promotion of metalloproteinase 9, which was associated with increased mortality and cardiac rupture (He et al., 2011). This evidence concerns the gene CAMK2G and myocardial infarction.